LGALS1 and hepatocellular carcinoma: In mesenchymal cells, we found an enrichment of Galectin-1 (LGALS1), which has been associated with EMT in hepatocellular carcinoma, and an increase in genes associated with the biosynthetic pathway of gangliosides, which has been previously reported for ovarian cancer.45